Pavion Blue Capital’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.56M | Hold |
8,426
| – | – | 0.69% | 35 |
|
|
2025
Q1 | $1.77M | Hold |
8,426
| – | – | 0.84% | 35 |
|
|
2024
Q4 | $1.5M | Sell |
8,426
-250
| -3% | -$44.4K | 0.7% | 39 |
|
|
2024
Q3 | $1.71M | Sell |
8,676
-8
| -0.1% | -$1.58K | 0.8% | 37 |
|
|
2024
Q2 | $1.49M | Hold |
8,684
| – | – | 0.73% | 38 |
|
|
2024
Q1 | $1.58M | Hold |
8,684
| – | – | 0.78% | 40 |
|
|
2023
Q4 | $1.35M | Hold |
8,684
| – | – | 0.74% | 41 |
|
|
2023
Q3 | $1.16M | Hold |
8,684
| – | – | 0.71% | 41 |
|
|
2023
Q2 | $1.17M | Buy |
8,684
+220
| +3% | +$29.6K | 0.68% | 41 |
|
|
2023
Q1 | $1.35M | Hold |
8,464
| – | – | 0.83% | 37 |
|
|
2022
Q4 | $1.37M | Buy |
8,464
+300
| +4% | +$48.5K | 0.87% | 35 |
|
|
2022
Q3 | $1.1M | Buy |
8,164
+100
| +1% | +$13.4K | 0.79% | 37 |
|
|
2022
Q2 | $1.24M | Buy |
8,064
+15
| +0.2% | +$2.3K | 0.83% | 38 |
|
|
2022
Q1 | $1.31M | Buy |
8,049
+300
| +4% | +$48.6K | 0.76% | 36 |
|
|
2021
Q4 | $1.05M | Sell |
7,749
-259
| -3% | -$35.1K | 0.61% | 40 |
|
|
2021
Q3 | $864K | Hold |
8,008
| – | – | 0.54% | 46 |
|
|
2021
Q2 | $902K | Sell |
8,008
-500
| -6% | -$56.3K | 0.54% | 48 |
|
|
2021
Q1 | $921K | Sell |
8,508
-43
| -0.5% | -$4.66K | 0.61% | 45 |
|
|
2020
Q4 | $916K | Hold |
8,551
| – | – | 0.63% | 42 |
|
|
2020
Q3 | $749K | Hold |
8,551
| – | – | 0.58% | 44 |
|
|
2020
Q2 | $840K | Buy |
8,551
+80
| +0.9% | +$7.86K | 0.73% | 37 |
|
|
2020
Q1 | $645K | Buy |
8,471
+3,588
| +73% | +$273K | 0.67% | 39 |
|
|
2019
Q4 | $432K | Buy |
+4,883
| New | +$432K | 0.43% | 38 |
|